AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Kalviainen, R Nousiainen, I
Citation: R. Kalviainen et I. Nousiainen, Visual field defects with vigabatrin - Epidemiology and therapeutic implications, CNS DRUGS, 15(3), 2001, pp. 217-230

Authors: Salmenpera, T Kalviainen, R Partanen, K Pitkanen, A
Citation: T. Salmenpera et al., Hippocampal and amygdaloid damage in partial epilepsy - A cross-sectional MRI study of 241 patients, EPILEPSY R, 46(1), 2001, pp. 69-82

Authors: Kalviainen, R
Citation: R. Kalviainen, Monotherapy trial design: conversion versus de novo, EPILEPSY R, 45(1-3), 2001, pp. 75-78

Authors: Nousiainen, I Mantyjarvi, M Kalviainen, R
Citation: I. Nousiainen et al., No reversion in vigabatrin-associated visual field defects, NEUROLOGY, 57(10), 2001, pp. 1916-1917

Authors: Kalviainen, R
Citation: R. Kalviainen, Long-term safety of tiagabine, EPILEPSIA, 42, 2001, pp. 46-48

Authors: Lamusuo, S Jutila, L Ylinen, A Kalviainen, R Mervaala, E Haaparanta, M Jaaskelainen, S Partanen, K Vapalahti, M Rinne, J
Citation: S. Lamusuo et al., [F-18]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage, ARCH NEUROL, 58(6), 2001, pp. 933-939

Authors: Schmidt, D Arroyo, S Baulac, M Dam, M Dulac, O Friis, ML Kalviainen, R Kramer, G van Parys, J Pedersen, B Sachdeo, R
Citation: D. Schmidt et al., Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view, ACT NEUR SC, 104(3), 2001, pp. 167-170

Authors: Nousiainen, I Mantyjarvi, M Kalviainen, R
Citation: I. Nousiainen et al., Visual function in patients treated with the GABAergic anticonvulsant drugtiagabine, CLIN DRUG I, 20(6), 2000, pp. 393-400

Authors: Salmenpera, T Kalviainen, R Partanen, K Pitkanen, A
Citation: T. Salmenpera et al., Quantitative MRI volumetry of the entorhinal cortex in temporal lobe epilepsy, SEIZURE-E J, 9(3), 2000, pp. 208-215

Authors: Schmidt, D Gram, L Brodie, M Kramer, G Perucca, E Kalviainen, R Elger, CE
Citation: D. Schmidt et al., Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician, EPILEPSY R, 41(3), 2000, pp. 245-251

Authors: Salmenpera, T Kalviainen, R Partanen, K Mervaala, E Pitkanen, A
Citation: T. Salmenpera et al., MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus, EPILEPSY R, 40(2-3), 2000, pp. 155-170

Authors: Nousiainen, I Kalviainen, R Mantyjarvi, M
Citation: I. Nousiainen et al., Color vision in epilepsy patients treated with vigabatrin or carbamazepinemonotherapy, OPHTHALMOL, 107(5), 2000, pp. 884-888

Authors: Lamusuo, S Pitkanen, A Jutila, L Ylinen, A Partanen, K Kalviainen, R Ruottinen, HM Oikonen, V Nagren, K Lehikoinen, P Vapalahti, M Vainio, P Rinne, JO
Citation: S. Lamusuo et al., [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology, NEUROLOGY, 54(12), 2000, pp. 2252-2260

Authors: Nousiainen, I Kalviainen, R Mantyjarvi, M
Citation: I. Nousiainen et al., Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers, BR J OPHTH, 84(6), 2000, pp. 622-625

Authors: Aikia, M Kalviainen, R Mervaala, E Riekkinen, PJ
Citation: M. Aikia et al., Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor, EPILEPSY R, 37(2), 1999, pp. 159-167

Authors: Kalviainen, R Nousiainen, I Mantyjarvi, M Nikoskelainen, E Partanen, J Partanen, K Riekkinen, P
Citation: R. Kalviainen et al., Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual fielddefects, NEUROLOGY, 53(5), 1999, pp. 922-926

Authors: Kalviainen, R Salmenpera, T Partanen, K Vainio, P Riekkinen, P Pitkanen, A
Citation: R. Kalviainen et al., Hippocampal damage and the onset of epilepsy - Reply, NEUROLOGY, 52(8), 1999, pp. 1719-1720

Authors: Kalviainen, R
Citation: R. Kalviainen, Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy, J INTEL DIS, 42, 1998, pp. 63-67

Authors: Mikkonen, M Soininen, H Kalviainen, R Tapiola, T Ylinen, A Vapalahti, M Paljarvi, L Pitkanen, A
Citation: M. Mikkonen et al., Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex, ANN NEUROL, 44(6), 1998, pp. 923-934
Risultati: 1-19 |